Fifth Third Bancorp’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIL
NMC
ACA
EAM
MF
PCM
FM
OPU
UOC
VI
Fifth Third Bancorp's TRIL Position: Q3 2021 in Review
Fifth Third Bancorp sold out of Trillium Therapeutics Inc. (TRIL) in Q3 2021, closing a stake of 370 shares — an estimated $4K sold.
Fifth Third Bancorp first reported a position in TRIL in Q2 2021 and held it in 1 quarter. The position peaked at $4K in Q2 2021. 181 funds tracked by Wall St. Rank hold TRIL as of Q3 2021.
- Fifth Third Bancorp reported no remaining Trillium Therapeutics Inc. position as of Q3 2021 after selling out during the quarter.
- Fifth Third Bancorp sold 370 Trillium Therapeutics Inc. shares in Q3 2021, an estimated $4K.
- Fifth Third Bancorp first reported a position in Trillium Therapeutics Inc. in Q2 2021 and held it in 1 quarter.
- Fifth Third Bancorp's Trillium Therapeutics Inc. position peaked at $4K in Q2 2021.
- 181 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q3 2021.
Based on Fifth Third Bancorp's 13F filing for Q3 2021, filed 15 Oct 2021.